이 누리집은 대한민국 공식 전자정부 누리집입니다.
Biz News Korea(Eng)
Korea’s Dongkwang Pharm wins patent for potential substance to treat Parkinson`s disease
- Collected
- 2018.01.04
- Distributed
- 2018.01.08
- Source
- Go Direct
Korea’s Dongkwang Pharm wins patent for potential substance to treat Parkinson''''s disease
![[Photo provided by Dongkwang Pharm] <br><br>](http://file.mk.co.kr/meet/neds/2018/01/image_readtop_2018_8507_15150456083160154.jpg)
[Photo provided by Dongkwang Pharm]
The company said the potential of the substance was identified during its state-commissioned research project conducted with researchers from two local universities Kyung hee University and Chonnam National University
The company is planning to apply for a local phase 2 clinical trial authorization of the new substance as soon as possible. Parkinson`s disease is caused by a lack of dopamine, a chemical in the brain that transmits neural signals. There is currently no cure for Parkinson`s disease, but treatments such as dopamine precursors and anticholinergics are available to help relieve the symptoms.
Dongkwang Pharm founded in 1962 is a mid-sized manufacturer of about 120 prescription and generic drugs in Korea. Key products include internal solid medicines, antibiotics, solutions for injection and ointments.
The company said it has strengthened its research activities in developing new formulations and natural substances since relocation of its R&D center in 2016.
By Kim Myung-hwan and Minu Kim
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]